Cancer of Unknown Origin Recruiting Phase 1 / 2 Trials for Cephalexin (DB00567)

IndicationStatusPhase
DBCOND0080662 (Cancer of Unknown Origin)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03628079A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.Treatment